• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
FBIO

FBIO

Fortress Biotech, Inc.

NASDAQHealthcareBiotechnologyUS

USD2.61

-0.04 (-1.51%)

Rating:A-

Company Profile

CEO

Lindsay Allan Rosenwald

IPO Date

2011-11-17

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.65

Prev. Close

$2.65

Day Low

$2.60

Day High

$2.65

52W Low

$1.70

52W High

$4.53

Market Cap

$0.09B

Volume

0.28M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

31.5%

Avg Negative

10.7%

Avg Neutral

57.8%

News Feed

Diversifying to Conquer: Fortress Biotech (FBIO) Partnering Expansion Driving Progress in Cancer Immunotherapy and Rare Disease Therapeutics

Benzinga·6/3/2021·↑ positive

Fortress Biotech to Participate in Three June 2021 Virtual Investor Conferences

GlobeNewsWire·6/1/2021·↑ positive

Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate Highlights

GlobeNewsWire·5/16/2021·↑ positive

Fortress Biotech Announces Exclusive License Agreement With Fuji Yakuhin to Develop Dotinurad in North America and Europe

GlobeNewsWire·5/10/2021·↑ positive

Fortress Bio: Interesting Model Of Doing Medicine

Seeking Alpha·4/29/2021·↑ positive

Why Fortress Biotech Stock Is Sinking Today

The Motley Fool·4/13/2021·↓ negative

Is the Options Market Predicting a Spike in Fortress Biotech (FBIO) Stock?

Zacks Investment Research·4/12/2021·↑ positive

Fortress Biotech (FBIO) Surges 11.5%: Is This an Indication of Further Gains?

Zacks Investment Research·4/12/2021·↑ positive

FBIO Stock: Over 10% Increase Pre-Market Explanation

Pulse2·4/12/2021·↑ positive

Fortress Biotech to Participate in the 20th Annual Needham Virtual Healthcare Conference

GlobeNewsWire·4/7/2021·↑ positive